Elias Lagonik

1PUBLICATIONS
6CO-AUTHORS
Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 07, 2024
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy.

Laura N Eadie, Elias Lagonik, Elyse C Page

Pageof 1

Frequent Collaborators

1 joint publications

Laura N Eadie

1 joint publications

Elyse C Page

1 joint publications

Susan L Heatley

1 joint publications

Barbara J McClure